|
27 Apr 2010 |
VaxInnate’s VAX125 Seasonal Flu Vaccine Shown Safe and Highly Immunogenic in Phase II Study of Elderly Subjects
|
|
26 Apr 2010 |
Pevion Announces Excellent Preclinical Results for PEV4 RSV Vaccine Candidate
|
|
23 Apr 2010 |
AFFiRiS AG: Alzheimer's Vaccine AD02 Already in Clinical Phase II
|
|
22 Apr 2010 |
Fraunhofer Centers in Newark, DE, and at Boston University Develop Plant-Based Vaccine Factory based on Proprietary Expression Technology of iBio, Inc.
|
|
22 Apr 2010 |
Vical Presents Encouraging Preliminary Data From Final 12-month Follow-up in TransVax(TM) CMV Vaccine Phase 2 Transplant Recipient Trial
|
|
22 Apr 2010 |
Immunovaccine Signs Research Agreement with Dana-Farber Cancer Institute
|
|
21 Apr 2010 |
Merck Obtains Exclusive Rights to Market and Distribute MassBiologics' Tetanus-Diphtheria (Td) Vaccine in the U.S.
|
|
19 Apr 2010 |
NanoBio Launches Development Program for a Therapeutic Intranasal Vaccine for the Treatment of Hepatitis B
|
|
19 Apr 2010 |
Stallergenes: Positive Results for Oralair(R) Phase III Trial in the USA
|
|
19 Apr 2010 |
Systemic and Antigen-Specific Immune Responses in Patients Treated With Cancer Vaccine BPX-101 Correlate With Clinical Response
|
|
19 Apr 2010 |
GlobeImmune's Hepatitis C Product Candidate Improves End of Treatment Response in All IL-28 B Genotypes, With the Greatest Effect in the Hardest-to-Treat Patients
|
|
19 Apr 2010 |
ABRAXANE in Combination with Gemcitabine Increases Survival in First-Line Treatment of Advanced Pancreatic Cancer in Phase I/II Study
|
|
19 Apr 2010 |
New Preclinical Breast Cancer Study Shows Peregrine's PS-Targeting Antibodies Can Reverse Tumor-Induced Immune Suppression
|
|
15 Apr 2010 |
Advaxis Initiates Phase II Cervical Dysplasia (CIN) Trial
|
|
15 Apr 2010 |
GlobeImmune GI-5005 HCV Product Candidate Improves Sustained Virologic Response by 10 Percent, Demonstrating Potential to Be First Therapeutic Vaccine for HCV
|
|
15 Apr 2010 |
Dynavax's Chronic Kidney Disease Study Confirms HEPLISAV's Enhanced Seroprotection Against HBV Infection
|
|
15 Apr 2010 |
Genocea Biosciences Enters Into Cooperative Research and Development Agreement with U.S. Military to Develop Malaria Vaccine
|
|
14 Apr 2010 |
Aeras and Crucell Announce Start of Phase II TB study in South Africa
|
|
12 Apr 2010 |
Sanofi Pasteur Partners with U.S. Naval Medical Research Center to Advance Development of Travelers’ Diarrhea Vaccine
|
|
12 Apr 2010 |
ENCOURAGING DATA FROM MALARIA STUDY PRESENTED
|
|
08 Apr 2010 |
Inovio Biomedical Completes Enrollment of Cervical Cancer Therapeutic Vaccine Study
|
|
07 Apr 2010 |
Vivalis Achieves Milestone With Glaxosmithkline in the Development of Human Flu Vaccines Based on Eb66
|
|
06 Apr 2010 |
Crucell Announces Collaboration with GlaxoSmithKline Biologicals on Second Generation Malaria Vaccine Candidate
|
|
06 Apr 2010 |
MOLOGEN AG receives funding to develop a DNA vaccine against hepatitis B
|
|
05 Apr 2010 |
Immunovaccine Announces the Publication of DPX-0907 Preclinical Study
|
